|
Volumn 15, Issue 6, 2001, Pages
|
Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Antigenic variability; Biological; Clinical trials; HIV genetic; HIV vaccine development
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIGENIC VARIATION;
CELLULAR IMMUNITY;
CONFERENCE PAPER;
DRUG DESIGN;
DRUG TARGETING;
ENDEMIC DISEASE;
GENETIC VARIABILITY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMORAL IMMUNITY;
IMMUNOTHERAPY;
INFECTION CONTROL;
METHODOLOGY;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTECTION;
SEROTYPING;
STRAIN DIFFERENCE;
VACCINATION;
VIRAL GENETICS;
VIRUS ENVELOPE;
VIRUS NEUTRALIZATION;
VIRUS REPLICATION;
AIDS VACCINES;
ANTIBODY FORMATION;
ANTIGENIC VARIATION;
HIV INFECTIONS;
HIV-1;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOTHERAPY, ACTIVE;
PUBLIC POLICY;
VIRAL LOAD;
WORLD HEALTH ORGANIZATION;
|
EID: 18344398562
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200104130-00030 Document Type: Conference Paper |
Times cited : (22)
|
References (0)
|